Nasdaq · CIK 0001579428
AXSM Axsome Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing 38 d ago. Close $168.35 on Oct 9, 2026, +39% from the 52-week low and -34% from the high.
Last 90 days
Net insider value
-$2.1M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$2.1M by 1 insider
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
AXSMOct 9, 2026 · close 168.35
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Axsome Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Mark L. Jacobson Chief Operating Officer sell | $2.1M 10,000 shares | -100% | - | |
| 33Weak | Hunter R. Murdock General Counsel sell | $1.4M 13,514 shares | -180% | +26% from low-27% from high | |
| 33Weak | Hunter R. Murdock General Counsel sell | $2.3M 22,500 shares | -300% | +27% from low-26% from high | |
| 45Moderate | Mark L. Jacobson Chief Operating Officer sell | $2.8M 25,000 shares | -81% | +37% from low-20% from high | |
| 30Weak | Mark Coleman director sell | $783k 7,500 shares | -14% | +30% from low-25% from high | |
| 38Weak | Mark L. Jacobson Chief Operating Officer sell | $4.2M 40,673 shares | -154% | +30% from low-25% from high | |
| 37Weak | Mark Coleman director sell | $322k 3,000 shares | -5% | +35% from low-21% from high | |
| 22Weak | Nick Pizzie Chief Financial Officer sell | $2.0M 15,000 shares | -28% | - |
Transactions
The last 66 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Mark L. Jacobson Chief Operating Officer | MOption exercise Common Stock10b5-1 | +10,000 | $12.95 | $130k | 10,000 | 38 d ago |
| Sep 3, 2026 | Mark L. Jacobson Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -10,000 | $208.65 | $2.1M | 0 | 38 d ago |
| Sep 3, 2026 | Mark L. Jacobson Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 104,954 | 38 d ago |
| Jun 20, 2025 | Hunter R. Murdock General Counsel | MOption exercise Common Stock10b5-1 | +7,500 | $29.91 | $224k | 7,500 | Jun 23, 2025 |
| Jun 20, 2025 | Hunter R. Murdock General Counsel | SOpen-market sale Common Stock10b5-1 | -7,500 | $102.47 | $769k | 0 | Jun 23, 2025 |
| Jun 23, 2025 | Hunter R. Murdock General Counsel | MOption exercise Common Stock10b5-1 | +6,014 | $29.91 | $180k | 6,014 | Jun 23, 2025 |
| Jun 23, 2025 | Hunter R. Murdock General Counsel | SOpen-market sale Common Stock10b5-1 | -6,014 | $100.12 | $602k | 0 | Jun 23, 2025 |
| Jun 20, 2025 | Hunter R. Murdock General Counsel | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 22,383 | Jun 23, 2025 |
| Jun 23, 2025 | Hunter R. Murdock General Counsel | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,014 | $0.00 | $0 | 16,369 | Jun 23, 2025 |
| Jun 16, 2025 | Hunter R. Murdock General Counsel | MOption exercise Common Stock10b5-1 | +7,500 | $29.91 | $224k | 7,500 | Jun 18, 2025 |
| Jun 16, 2025 | Hunter R. Murdock General Counsel | SOpen-market sale Common Stock10b5-1 | -7,500 | $102.42 | $768k | 0 | Jun 18, 2025 |
| Jun 17, 2025 | Hunter R. Murdock General Counsel | MOption exercise Common Stock10b5-1 | +7,500 | $29.91 | $224k | 7,500 | Jun 18, 2025 |
| Jun 17, 2025 | Hunter R. Murdock General Counsel | SOpen-market sale Common Stock10b5-1 | -7,500 | $100.26 | $752k | 0 | Jun 18, 2025 |
| Jun 18, 2025 | Hunter R. Murdock General Counsel | MOption exercise Common Stock10b5-1 | +7,500 | $29.91 | $224k | 7,500 | Jun 18, 2025 |
| Jun 18, 2025 | Hunter R. Murdock General Counsel | SOpen-market sale Common Stock10b5-1 | -7,500 | $100.90 | $757k | 0 | Jun 18, 2025 |
| Jun 16, 2025 | Hunter R. Murdock General Counsel | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 44,883 | Jun 18, 2025 |
| Jun 17, 2025 | Hunter R. Murdock General Counsel | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 37,383 | Jun 18, 2025 |
| Jun 18, 2025 | Hunter R. Murdock General Counsel | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 29,883 | Jun 18, 2025 |
| Jun 6, 2025 | Susan Mahony director | AGrant or award Stock Option (Right to Buy)derivative | +3,166 | $0.00 | $0 | 3,166 | Jun 10, 2025 |
| Jun 6, 2025 | Mark Coleman director | AGrant or award Stock Option (Right to Buy)derivative | +3,166 | $0.00 | $0 | 3,166 | Jun 10, 2025 |
| Jun 6, 2025 | Roger Jeffs director | AGrant or award Stock Option (Right to Buy)derivative | +3,166 | $0.00 | $0 | 3,166 | Jun 10, 2025 |
| Jun 6, 2025 | Mark E Saad director | AGrant or award Stock Option (Right to Buy)derivative | +3,166 | $0.00 | $0 | 3,166 | Jun 10, 2025 |
| Jun 9, 2025 | Mark L. Jacobson Chief Operating Officer | MOption exercise Common Stock10b5-1 | +25,000 | $8.02 | $201k | 30,783 | Jun 10, 2025 |
| Jun 6, 2025 | Susan Mahony director | AGrant or award Restricted Stock Unitsderivative | +1,429 | $0.00 | $0 | 1,429 | Jun 10, 2025 |
| Jun 6, 2025 | Mark E Saad director | AGrant or award Restricted Stock Unitsderivative | +1,429 | $0.00 | $0 | 1,429 | Jun 10, 2025 |
| Jun 9, 2025 | Mark L. Jacobson Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -25,000 | $110.44 | $2.8M | 5,783 | Jun 10, 2025 |
| Jun 6, 2025 | Roger Jeffs director | AGrant or award Restricted Stock Unitsderivative | +1,429 | $0.00 | $0 | 1,429 | Jun 10, 2025 |
| Jun 6, 2025 | Mark Coleman director | AGrant or award Restricted Stock Unitsderivative | +1,429 | $0.00 | $0 | 1,429 | Jun 10, 2025 |
| Jun 9, 2025 | Mark L. Jacobson Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 0 | Jun 10, 2025 |
| May 27, 2025 | Mark Coleman director | SOpen-market sale Common Stock10b5-1 | -3,750 | $105.47 | $396k | 50,387 | May 29, 2025 |
| May 28, 2025 | Mark Coleman director | SOpen-market sale Common Stock10b5-1 | -3,750 | $103.43 | $388k | 46,637 | May 29, 2025 |
| May 27, 2025 | Mark L. Jacobson Chief Operating Officer | MOption exercise Common Stock10b5-1 | +20,673 | $6.47 | $134k | 26,456 | May 28, 2025 |
| May 27, 2025 | Mark L. Jacobson Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -20,673 | $104.66 | $2.2M | 5,783 | May 28, 2025 |
| May 28, 2025 | Mark L. Jacobson Chief Operating Officer | MOption exercise Common Stock10b5-1 | +20,000 | $6.47 | $129k | 25,783 | May 28, 2025 |
| May 28, 2025 | Mark L. Jacobson Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -20,000 | $103.45 | $2.1M | 5,783 | May 28, 2025 |
| May 27, 2025 | Mark L. Jacobson Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,673 | $0.00 | $0 | 0 | May 28, 2025 |
| May 28, 2025 | Mark L. Jacobson Chief Operating Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,000 | $0.00 | $0 | 0 | May 28, 2025 |
| May 20, 2025 | Mark Coleman director | SOpen-market sale Common Stock | -3,000 | $107.49 | $322k | 54,137 | May 20, 2025 |
| Feb 21, 2025 | Hunter R. Murdock General Counsel | AGrant or award Employee Stock Option (Right to Buy)derivative | +7,816 | $0.00 | $0 | 7,816 | Feb 25, 2025 |
| Feb 21, 2025 | Susan Mahony director | AGrant or award Stock Option (Right to Buy)derivative | +1,312 | $0.00 | $0 | 1,312 | Feb 25, 2025 |
| Feb 21, 2025 | Roger Jeffs director | AGrant or award Stock Option (Right to Buy)derivative | +1,408 | $0.00 | $0 | 1,408 | Feb 25, 2025 |
| Feb 21, 2025 | Mark E Saad director | AGrant or award Stock Option (Right to Buy)derivative | +1,494 | $0.00 | $0 | 1,494 | Feb 25, 2025 |
| Feb 21, 2025 | Ari Maizel Chief Commercial Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +7,816 | $0.00 | $0 | 7,816 | Feb 25, 2025 |
| Feb 21, 2025 | Nick Pizzie Chief Financial Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +9,516 | $0.00 | $0 | 9,516 | Feb 25, 2025 |
| Feb 21, 2025 | Mark L. Jacobson Chief Operating Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +10,875 | $0.00 | $0 | 10,875 | Feb 25, 2025 |
| Feb 21, 2025 | Herriot Tabuteau Chief Executive Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +28,887 | $0.00 | $0 | 28,887 | Feb 25, 2025 |
| Feb 21, 2025 | Mark L. Jacobson Chief Operating Officer | AGrant or award Restricted Stock Unitsderivative | +10,769 | $0.00 | $0 | 10,769 | Feb 25, 2025 |
| Feb 21, 2025 | Nick Pizzie Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +9,423 | $0.00 | $0 | 9,423 | Feb 25, 2025 |
| Feb 21, 2025 | Herriot Tabuteau Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +28,609 | $0.00 | $0 | 28,609 | Feb 25, 2025 |
| Feb 21, 2025 | Hunter R. Murdock General Counsel | AGrant or award Restricted Stock Unitsderivative | +7,740 | $0.00 | $0 | 7,740 | Feb 25, 2025 |
| Feb 21, 2025 | Ari Maizel Chief Commercial Officer | AGrant or award Restricted Stock Unitsderivative | +7,740 | $0.00 | $0 | 7,740 | Feb 25, 2025 |
| Feb 24, 2025 | Herriot Tabuteau Chief Executive Officer | AGrant or award Performance Stock Unitsderivative | +28,609 | $0.00 | $0 | 28,609 | Feb 25, 2025 |
| Feb 24, 2025 | Mark L. Jacobson Chief Operating Officer | AGrant or award Performance Stock Unitsderivative | +10,769 | $0.00 | $0 | 10,769 | Feb 25, 2025 |
| Feb 24, 2025 | Nick Pizzie Chief Financial Officer | AGrant or award Performance Stock Unitsderivative | +9,423 | $0.00 | $0 | 9,423 | Feb 25, 2025 |
| Feb 24, 2025 | Hunter R. Murdock General Counsel | AGrant or award Performance Stock Unitsderivative | +7,740 | $0.00 | $0 | 7,740 | Feb 25, 2025 |
| Feb 24, 2025 | Ari Maizel Chief Commercial Officer | AGrant or award Performance Stock Unitsderivative | +7,740 | $0.00 | $0 | 7,740 | Feb 25, 2025 |
| Feb 13, 2025 | Nick Pizzie Chief Financial Officer | MOption exercise Common Stock10b5-1 | +12,000 | $3.50 | $42k | 54,187 | Feb 14, 2025 |
| Feb 13, 2025 | Nick Pizzie Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -12,000 | $129.86 | $1.6M | 42,187 | Feb 14, 2025 |
| Feb 14, 2025 | Nick Pizzie Chief Financial Officer | MOption exercise Common Stock10b5-1 | +3,000 | $3.50 | $11k | 45,187 | Feb 14, 2025 |
| Feb 14, 2025 | Nick Pizzie Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -3,000 | $131.07 | $393k | 42,187 | Feb 14, 2025 |
| Feb 13, 2025 | Nick Pizzie Chief Financial Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,000 | $3.50 | $42k | 0 | Feb 14, 2025 |
| Feb 14, 2025 | Nick Pizzie Chief Financial Officer | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,000 | $3.50 | $11k | 0 | Feb 14, 2025 |
| Jan 3, 2025 | Mark Coleman director | MOption exercise Common Stock | +9,127 | $9.00 | $82k | 57,137 | Jan 6, 2025 |
| Jan 3, 2025 | Mark Coleman director | MOption exercise Stock Option (Right to Buy)derivative | -9,127 | $0.00 | $0 | 0 | Jan 6, 2025 |
| Nov 19, 2024 | Mark Coleman director | MOption exercise Common Stock | +33,410 | $5.94 | $198k | 48,010 | Nov 20, 2024 |
| Nov 19, 2024 | Mark Coleman director | MOption exercise Stock Option (Right to Buy)derivative | -33,410 | $0.00 | $0 | 0 | Nov 20, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Mark Colemandirector
- Roger Jeffsceo, officer, director
- Mark L. JacobsonChief Operating Officer
- Susan Mahonydirector
- Ari MaizelChief Commercial Officer
- Hunter R. MurdockGeneral Counsel
- Nick PizzieChief Financial Officer
- Mark E Saaddirector
- Herriot TabuteauChief Executive Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.